Literature DB >> 25860203

Goal-Directed Resuscitative Interventions During Pediatric Interfacility Transport.

Michael H Stroud1, Ronald C Sanders, M Michele Moss, Janice E Sullivan, Parthak Prodhan, Maria Melguizo-Castro, Todd Nick.   

Abstract

OBJECTIVES: This article reports results of the first National Institutes of Health-funded prospective interfacility transport study to determine the effect of goal-directed therapy administered by a specialized pediatric team to critically ill children with the systemic inflammatory response syndrome. We hypothesized that goal-directed therapy during interfacility transport would decrease hospital length of stay, prevent multiple organ dysfunction, and reduce subsequent ICU interventions.
DESIGN: Before-and-after intervention trial.
SETTING: During interfacility transport of critically ill patients by a specialized pediatric transport team, back to a tertiary care children's hospital. PATIENTS: Before-and-after intervention trial.
DESIGN: Interfacility pediatric transport patients, age 1 month to 17 years, with systemic inflammatory response syndrome.
INTERVENTIONS: Prospective data were collected on all pediatric interfacility transport patients with systemic inflammatory response syndrome transported by the Angel One Transport team at Arkansas Children's Hospital. A 10-month data collection period was followed by institution of a goal-directed resuscitation protocol. Data were subsequently collected for 10 additional months followed by comparison of pre- and postintervention groups. All transport personnel underwent training with didactics and high-fidelity simulation until mastery with goal-directed resuscitation was achieved.
MEASUREMENTS AND MAIN RESULTS: All transport patients were screened for systemic inflammatory response syndrome using established variables and 235 (123 preintervention and 112 postintervention) were enrolled. Univariate analysis revealed shorter hospital stay (11 ± 15 d vs 7 ± 10 d; p = 0.02) and fewer required therapeutic ICU interventions in the postintervention group (Therapeutic Intervention Scoring System-28 Scores, 19.4 ± 6.8 vs 17.3 ± 6.6; p = 0.04). ICU stay and prevalence of organ dysfunction were not statistically different. Multivariable analysis showed a 1.6-day (95% CI, 1.3-2.03; p = 0.02) decrease in hospital stay in the postintervention group.
CONCLUSIONS: This study suggests that goal-directed therapy administered by a specialized pediatric transport team has the potential to impact the outcomes of critically ill children. Findings from this study should be confirmed across multiple institutions, but have the potential to impact the clinical outcomes of critically ill children with systemic inflammatory response syndrome.

Entities:  

Mesh:

Year:  2015        PMID: 25860203      PMCID: PMC4506208          DOI: 10.1097/CCM.0000000000001021

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Development of a pediatric multiple organ dysfunction score: use of two strategies.

Authors:  S Leteurtre; A Martinot; A Duhamel; F Gauvin; B Grandbastien; T V Nam; F Proulx; J Lacroix; F Leclerc
Journal:  Med Decis Making       Date:  1999 Oct-Dec       Impact factor: 2.583

2.  Advanced life support for out-of-hospital respiratory distress.

Authors:  Ian G Stiell; Daniel W Spaite; Brian Field; Lisa P Nesbitt; Doug Munkley; Justin Maloney; Jon Dreyer; Lorraine Luinstra Toohey; Tony Campeau; Eugene Dagnone; Marion Lyver; George A Wells
Journal:  N Engl J Med       Date:  2007-05-24       Impact factor: 91.245

3.  Pediatric specialized transport teams are associated with improved outcomes.

Authors:  Richard A Orr; Kathryn A Felmet; Yong Han; Karin A McCloskey; Michelle A Dragotta; Debra M Bills; Bradley A Kuch; R Scott Watson
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 4.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

5.  Noninvasive cerebral oximeter as a surrogate for mixed venous saturation in children.

Authors:  Adnan T Bhutta; Jesse W Ford; James G Parker; Parthak Prodhan; Eudice E Fontenot; Paul M Seib; Brittany I Stroope; Elizabeth A Frazier; Michael L Schmitz; Jonathan J Drummond-Webb; William R Morrow
Journal:  Pediatr Cardiol       Date:  2007-01-09       Impact factor: 1.655

6.  Use of near-infrared spectroscopy for estimation of renal oxygenation in children with heart disease.

Authors:  Laura A Ortmann; Eudice E Fontenot; Paul M Seib; Brian K Eble; Ross Brown; Adnan T Bhutta
Journal:  Pediatr Cardiol       Date:  2011-03-29       Impact factor: 1.655

7.  Enhanced monitoring improves pediatric transport outcomes: a randomized controlled trial.

Authors:  Michael H Stroud; Parthak Prodhan; Michele Moss; Richard Fiser; Stephen Schexnayder; Kanwaljeet Anand
Journal:  Pediatrics       Date:  2010-12-20       Impact factor: 7.124

8.  Effect of altitude on cerebral oxygenation during pediatric interfacility transport.

Authors:  Michael H Stroud; Punkaj Gupta; Parthak Prodhan
Journal:  Pediatr Emerg Care       Date:  2012-04       Impact factor: 1.454

9.  The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases.

Authors:  Nelly Ninis; Claire Phillips; Linda Bailey; Jon I Pollock; Simon Nadel; Joseph Britto; Ian Maconochie; Andrew Winrow; Pietro G Coen; Robert Booy; Michael Levin
Journal:  BMJ       Date:  2005-06-25

10.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.